Iambic Therapeutics, an AI-powered drug development company backed by Nvidia, raised $150 million through a U.S. IPO. The company offered about 9.38 million shares at $16 each.

The offering price was in the middle of the expected range of $15–$17 per share, implying a valuation of about $758 million. Iambic is expected to begin trading on Nasdaq on October 15 under the ticker IAM.

The proceeds will be used to advance the development of three early-stage cancer drug candidates. ARK and Druckenmiller’s family office had previously expressed interest in purchasing shares worth up to $60 million in total.

Source: https://tintucbitcoin.com/cong-ty-duoc-ai-iambic-huy-dong-150-trieu-usd-qua-ipo-tai-my/

Thank you for reading this article!

Like, comment, and follow TinTucBitcoin to stay up to date with the latest news about the cryptocurrency market and never miss any important information!

$BTC $ETH $BNB $XRP $SOL